Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis.

Chris KatoSatoru MorimotoShinichi TakahashiYugaku DatéKensuke OkadaHideyuki OkanoJin NakaharaDaisuke Ito

Published in: Journal of neurology (2021)

Participation in a clinical trial decreases the willingness to prolong life after the clinical trial. The present results are meaningful when designing clinical trials and discussing life-sustaining treatments with ALS patients.

Keyphrases

clinical trial
amyotrophic lateral sclerosis
phase ii
end stage renal disease
decision making
open label
double blind
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
physical activity